Literature DB >> 17696272

Medical insurance, socioeconomic status, and age of onset of endstage renal disease in patients with lupus nephritis.

Michael M Ward1.   

Abstract

OBJECTIVE: Limited access to care may hasten progression to endstage renal disease (ESRD) in patients with lupus nephritis. We examined associations between type of medical insurance, socioeconomic status (SES), and age at onset of ESRD in a national, population-based cohort.
METHODS: Using the United States Renal Data System, incident cases of ESRD due to lupus nephritis in the US from January 1, 1996, to June 30, 2004, were examined in this cross-sectional study (n = 7971). Age at onset of ESRD was compared among patients with different types of medical insurance and by SES.
RESULTS: In each ethnic group, patients with private insurance were older at the onset of ESRD than those with no insurance or Medicaid. For example, whites with private insurance were on average 7.5 years older than those with no insurance and 8.2 years older than those with Medicaid. There were no differences in age at onset of ESRD between those with no insurance and those with Medicaid. SES, based on the socioeconomic characteristics of the patient's area of residence, was associated with age of onset of ESRD only in whites.
CONCLUSION: Among patients with lupus nephritis who develop ESRD, those with private medical insurance are older when they begin ESRD treatment than those with Medicaid or no insurance. Given that medical insurance is unrelated to the age at onset of lupus nephritis, these findings suggest that progression to ESRD varies with medical insurance status, possibly because of differences in quality of care or access to care.

Entities:  

Mesh:

Year:  2007        PMID: 17696272

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  23 in total

1.  Discrimination and Cumulative Disease Damage Among African American Women With Systemic Lupus Erythematosus.

Authors:  David H Chae; Cristina M Drenkard; Tené T Lewis; S Sam Lim
Journal:  Am J Public Health       Date:  2015-08-13       Impact factor: 9.308

2.  Identification and validation of lupus nephritis cases using administrative data.

Authors:  L B Chibnik; E M Massarotti; K H Costenbader
Journal:  Lupus       Date:  2010-02-23       Impact factor: 2.911

3.  Serious Infection Rates Among Children With Systemic Lupus Erythematosus Enrolled in Medicaid.

Authors:  Linda T Hiraki; Candace H Feldman; Francisco M Marty; Wolfgang C Winkelmayer; Hongshu Guan; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-09-21       Impact factor: 4.794

4.  Quality of care for incident lupus nephritis among Medicaid beneficiaries in the United States.

Authors:  Jinoos Yazdany; Candace H Feldman; Jun Liu; Michael M Ward; Michael A Fischer; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-04       Impact factor: 4.794

5.  Healthcare quality in systemic lupus erythematosus: using Donabedian's conceptual framework to understand what we know.

Authors:  Erica F Lawson; Jinoos Yazdany
Journal:  Int J Clin Rheumtol       Date:  2012-02

6.  Access to care and the incidence of endstage renal disease due to systemic lupus erythematosus.

Authors:  Michael M Ward
Journal:  J Rheumatol       Date:  2010-04-15       Impact factor: 4.666

7.  Inpatient health care utilization by children and adolescents with systemic lupus erythematosus and kidney involvement.

Authors:  Marie Tanzer; Cheryl Tran; Kassandra L Messer; Amber Kroeker; Emily Herreshoff; Larysa Wickman; Courtney Harkness; Peter Song; Debbie S Gipson
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-03       Impact factor: 4.794

8.  Determinants of peritoneal dialysis technique failure in incident US patients.

Authors:  Jenny I Shen; Aya A Mitani; Anjali B Saxena; Benjamin A Goldstein; Wolfgang C Winkelmayer
Journal:  Perit Dial Int       Date:  2012-10-02       Impact factor: 1.756

9.  Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004.

Authors:  Candace H Feldman; Linda T Hiraki; Jun Liu; Michael A Fischer; Daniel H Solomon; Graciela S Alarcón; Wolfgang C Winkelmayer; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2013-03

Review 10.  Use of Quality Measures to Identify Disparities in Health Care for Systemic Lupus Erythematosus.

Authors:  Shilpa Arora; Jinoos Yazdany
Journal:  Rheum Dis Clin North Am       Date:  2020-09-09       Impact factor: 2.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.